Low immunogenic potential of tocilizumab in patients with rheumatoid arthritis: Analysis of four phase 3 clinical trials Ramos-Remus, C., Genovese, M. C., Harre, R. A., Woodworth, T., Alecock, E. WILEY-LISS. 2008: S534

View details for Web of Science ID 000259244201253